LCS
Levin Capital Strategies’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-2,638
| Closed | -$393K | – | 210 |
|
2023
Q3 | $393K | Hold |
2,638
| – | – | 0.05% | 138 |
|
2023
Q2 | $355K | Hold |
2,638
| – | – | 0.04% | 148 |
|
2023
Q1 | $420K | Hold |
2,638
| – | – | 0.05% | 128 |
|
2022
Q4 | $426K | Hold |
2,638
| – | – | 0.06% | 130 |
|
2022
Q3 | $354K | Sell |
2,638
-500
| -16% | -$67.1K | 0.05% | 135 |
|
2022
Q2 | $481K | Hold |
3,138
| – | – | 0.06% | 122 |
|
2022
Q1 | $509K | Hold |
3,138
| – | – | 0.05% | 140 |
|
2021
Q4 | $425K | Hold |
3,138
| – | – | 0.04% | 182 |
|
2021
Q3 | $338K | Sell |
3,138
-12,420
| -80% | -$1.34M | 0.03% | 199 |
|
2021
Q2 | $1.75M | Sell |
15,558
-43,227
| -74% | -$4.87M | 0.18% | 71 |
|
2021
Q1 | $6.36M | Sell |
58,785
-265
| -0.4% | -$28.7K | 0.68% | 42 |
|
2020
Q4 | $6.33M | Sell |
59,050
-4,379
| -7% | -$469K | 0.71% | 38 |
|
2020
Q3 | $5.56M | Sell |
63,429
-6,045
| -9% | -$530K | 0.73% | 37 |
|
2020
Q2 | $6.82M | Buy |
69,474
+64,474
| +1,289% | +$6.33M | 0.94% | 32 |
|
2020
Q1 | $381K | Buy |
+5,000
| New | +$381K | 0.06% | 98 |
|
2019
Q4 | – | Sell |
-10,065
| Closed | -$762K | – | 210 |
|
2019
Q3 | $762K | Buy |
+10,065
| New | +$762K | 0.08% | 97 |
|
2016
Q2 | – | Sell |
-814,036
| Closed | -$46.5M | – | 336 |
|
2016
Q1 | $46.5M | Sell |
814,036
-1,590,903
| -66% | -$90.9M | 0.84% | 30 |
|
2015
Q4 | $142M | Buy |
2,404,939
+250,949
| +12% | +$14.9M | 2.5% | 11 |
|
2015
Q3 | $117M | Buy |
2,153,990
+285,345
| +15% | +$15.5M | 2% | 18 |
|
2015
Q2 | $126M | Buy |
1,868,645
+402,575
| +27% | +$27M | 1.86% | 17 |
|
2015
Q1 | $85.8M | Buy |
+1,466,070
| New | +$85.8M | 1.29% | 23 |
|